Zymeworks Inc. (ZYME) short interest & options flow
NASDAQZYME arrives at its November 13 earnings report having gained 19% in the past month, with short sellers and options traders offering sharply different reads on what comes next. The most telling divergence is in options. Traders have moved decisively toward calls in recent weeks: the put/call ratio has dropped to 1.13, nearly 1.4 standard deviations below its 20-day mean of 1.82…
- Market cap
- $2.17B
- Next earnings
- 13 Nov 2026
Key data as of 12 Nov 2026

ZYME news and analysis
RSSNo long-form analysis yet for ZYME. Pulse alerts and the live data picture are available on ORTEX.
Open ZYME on ORTEX →Want the live picture for ZYME?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ZYME — free to start on ORTEX.
Sign up for free →Open ZYME on ORTEX